Treatment of Subclinical Rejection Diagnosed by Protocol Biopsy of Kidney Transplants

Abstract

Early chronic allograft damage was associated with SCR and therapy appeared to ameliorate further immune-mediated injury, although the efficacy of corticosteroids alone may be inadequate. A controlled trial of therapy for SCR is warranted.